Clinical Trial Update: Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations

View source ↗

Summary

The NIH-sponsored clinical trial examining Epstein-Barr virus protein studies across ethnically diverse populations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus Infection

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Epstein-Barr Virus Infections | Status: COMPLETED